TP53 and prostate carcinoma: In agreement with our data, apigenin has been shown to induce G1 or G2/M arrest and apoptosis in human prostate carcinoma cells [40,41], human cervical carcinoma cells [42], and human hepatoma cells [43] through p53-dependent manner.